The homeobox transcription factor DUXBL controls exit from totipotency.
Maria Vega-SendinoFelipe F LüttmannTeresa OlbrichYanpu ChenCarsten KuennePaula SteinDesiree TiloGrace I CareyJiasheng ZhongVirginia SavyLenka RadonovaTianlin LuBechara SaykaliKee-Pyo KimCatherine N DomingoLeah SchülerStefan GüntherMette BentsenDarko BosnakovskiHans SchölerMichael KybaTapan K MaityLisa M Miller JenkinsMario LoosoCarmen J WilliamsJohnny KimSergio RuizPublished in: Nature genetics (2024)
In mice, exit from the totipotent two-cell (2C) stage embryo requires silencing of the 2C-associated transcriptional program. However, the molecular mechanisms involved in this process remain poorly understood. Here we demonstrate that the 2C-specific transcription factor double homeobox protein (DUX) mediates an essential negative feedback loop by inducing the expression of DUXBL to promote this silencing. We show that DUXBL gains accessibility to DUX-bound regions specifically upon DUX expression. Furthermore, we determine that DUXBL interacts with TRIM24 and TRIM33, members of the TRIM superfamily involved in gene silencing, and colocalizes with them in nuclear foci upon DUX expression. Importantly, DUXBL overexpression impairs 2C-associated transcription, whereas Duxbl inactivation in mouse embryonic stem cells increases DUX-dependent induction of the 2C-transcriptional program. Consequently, DUXBL deficiency in embryos results in sustained expression of 2C-associated transcripts leading to early developmental arrest. Our study identifies DUXBL as an essential regulator of totipotency exit enabling the first divergence of cell fates.
Keyphrases
- transcription factor
- poor prognosis
- binding protein
- single cell
- dna binding
- embryonic stem cells
- quality improvement
- cell therapy
- stem cells
- genome wide identification
- long non coding rna
- genome wide
- cell proliferation
- insulin resistance
- adipose tissue
- mesenchymal stem cells
- pregnancy outcomes
- dna methylation
- protein protein
- replacement therapy